Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Differences between tuberculous spondylitis and brucellar spondylitis].

J M Calvo Romero1, J L Ramos Salado, F García de la Llana

  • 1Servicio de Medicina Interna, Hospital Regional Universitario Infanta Cristina, Badajoz.

Anales De Medicina Interna (Madrid, Spain : 1984)
|August 16, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Extended anticoagulant treatment of venous thromboembolic disease with direct oral anticoagulants].

Semergen·2018
Same author

Low-molecular-weight heparins in patients with atrial fibrillation.

Revista clinica espanola·2017
Same author

Giant cell arteritis: diagnosis and treatment.

Revista clinica espanola·2015
Same author

Adult onset autoimmune lymphoproliferative syndrome due to somatic FAS mutation.

Internal medicine journal·2015
Same author

[New oral anticoagulants in the treatment of venous thromboembolic disease].

Semergen·2013
Same author

Letter: the role of stent in the treatment of Crohn's disease strictures - authors' reply.

Alimentary pharmacology & therapeutics·2013

Tuberculous spondylitis (TS) showed a longer diagnostic delay and more frequent abscesses compared to brucellar spondylitis (BS). These clinical and laboratory differences may aid in distinguishing between these spinal infections.

Area of Science:

  • Infectious Diseases
  • Rheumatology
  • Orthopedics

Background:

  • Spinal infections, including tuberculous spondylitis (TS) and brucellar spondylitis (BS), present diagnostic challenges.
  • Differentiating between TS and BS is crucial for appropriate empirical treatment and patient management.

Purpose of the Study:

  • To delineate the distinct clinical and laboratory features of tuberculous spondylitis (TS) and brucellar spondylitis (BS).
  • To identify key indicators that can assist in the differential diagnosis of these two conditions.

Main Methods:

  • A retrospective analysis was conducted on patients diagnosed with TS and BS between January 1992 and December 1998.
  • Clinical data and laboratory results were compared between the two groups.

Related Experiment Videos

Main Results:

  • Tuberculous spondylitis (TS) was diagnosed in 17 patients, and brucellar spondylitis (BS) in 10 patients.
  • TS exhibited a significantly longer diagnostic delay (27.9 weeks vs. 16 weeks, p=0.02).
  • Higher frequencies of immunosuppression, paravertebral/epidural abscesses, spinal cord compression, anemia, and elevated ESR were noted in TS, while BS cases more frequently presented with fever and residual vertebral pain. Lumbar spine involvement was common in both (58.8% TS, 70% BS).

Conclusions:

  • Distinct clinical and laboratory characteristics exist between tuberculous spondylitis (TS) and brucellar spondylitis (BS).
  • These differences can serve as valuable aids in the differential diagnosis.
  • Identifying these distinctions can guide empirical treatment decisions when definitive microbiological diagnosis is pending.